Antisense & RNAi Technology Market Research Reports & Industry Analysis
Antisense and RNAi technology has the potential to influence gene expression, offering new possibilities for treating previously challenging diseases. Staying informed about this evolving field is crucial, and MarketResearch.com's reports on the antisense and RNAi technology industry are valuable resources. These reports offer in-depth analyses of industry trends, challenges, and opportunities to help stakeholders make well-informed decisions based on accurate information.
Comprehensive Antisense and RNAi Technology Research
- Find research on a wide spectrum of key market segments including reagents, consumables, RNAi drug delivery, and RNAi therapeutics.
- Gain a holistic view of the industry by delving into RNAi market sizing, growth trajectories, technological breakthroughs, and competitor strategies.
- Understand the trends that are shaping the antisense and RNAi technology industry to stay ahead of the curve in an environment characterized by change.
Why Choose MarketResearch.com
Whether you're a busy executive or a professional in the field, our antisense and RNAi technology market research reports are designed to meet your information needs. These reports offer reliable data to support your business decisions and help you take advantage of emerging market opportunities. Embrace the value of knowledge and confidently explore the potential of the antisense and RNAi technology industry with MarketResearch.com.
Antisense & RNAi Technology Industry Research & Market Reports
-
RNAi Pesticides Market - A Global and Regional Analysis: Focus on Application, Product, and Competitive Landscape - Analysis and Forecast, 2024-2034
... segment within the broader agricultural industry, focusing on innovative pest control solutions that utilize RNA interference technology. In a favorable scenario, the market is valued at $1.20 billion in 2024 and is projected to expand ... Read More
-
RNAi Pesticides Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (Insect Pest Control, Weed Management, Disease Management, Resistance Management), By Crop Type (Agricultural Application, Non-Agricultural Application), By Product (Tropical RNAi Pesticide, Seed Embedded RANi, Transgenic RNAi, Others), By Region & Competition, 2019-2029F
... RNAi Pesticide, Seed Embedded RANi, Transgenic RNAi, Others), By Region & Competition, 2019-2029F Global RNAi Pesticides Market was valued at USD 1.23 Billion in 2023 and is expected to reach USD 2.15 Billion by 2029 ... Read More
-
Global RNAi Technologies Market Research Report 2024(Status and Outlook)
... the field of biotechnology. The major classes of RNAi are micro RNA and small interfering RNA. RNAi is said to be the replacement technology for the existing recombinant technology in the field of drug discovery ... Read More
-
Global RNA Interference (RNAi) Drug Delivery Market Growth 2024-2030
... growing demand in downstream market, the RNA Interference (RNAi) Drug Delivery is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the ... Read More
-
Nucleic Acid Therapeutics Market [Product: Anti-Sense Oligonucleotides (ASO), RNA Interference (RNAi), and RNA Aptamers; and Indication: Autoimmune Disorders, Infectious Diseases, Genetic Disorders, Cancer, and Others] - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... Forecast, 2024-2034 Nucleic Acid Therapeutics Market – Scope of Report TMR’s report on the global nucleic acid therapeutics market studies the past as well as the current growth trends and opportunities to gain valuable insights ... Read More
-
Global Rnai Drug Delivery Market 2024-2028
... the forecast period. The report on the RNAi drug delivery market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report ... Read More
-
Nucleic Acid Therapeutics Market (Product Type: RNA interference (RNAi) and Short Interfering RNAs, Antisense Oligonucleotides (ASOs), and Others; and Application: Autoimmune Disorders, Infectious Diseases, Genetic Disorders, Cancer, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... Share, Growth, Trends, and Forecast, 2024-2034 Nucleic Acid Therapeutics Market – Scope of Report TMR’s report on the global nucleic acid therapeutics market studies the past as well as the current growth trends and opportunities ... Read More
-
RNA Interference (RNAi)
... Billion by 2030, growing at a CAGR of 11.0% over the analysis period 2023-2030. Drug Discovery & Development Application, one of the segments analyzed in the report, is expected to record a 16.4% CAGR and ... Read More
-
RNAi Technologies and Global Markets
... reagents, diagnostics, therapeutics, and agriculture. BCC Research determines the current market status in each segment, examines its impact on future needs, and presents growth forecasts over the next six years. The report provides a detailed ... Read More
-
United Kingdom Rna Interference (Rnai) Drug Delivery Market Forecast 2024-2032
... It is set to reach a revenue of $20807.84 million by 2032. MARKET INSIGHTS The United Kingdom RNA interference (RNAi) drug delivery market is witnessing a notable surge in demand, primarily driven by the increasing ... Read More
-
Global Rna Interference (Rnai) Drug Delivery Market Forecast 2024-2032
... a CAGR of 22.24% during the forecast period. The base year considered for the study is 2023, and the estimated period is between 2024 and 2032. The RNAi technology has emerged as a promising therapeutic ... Read More
-
Germany Rna Interference (Rnai) Drug Delivery Market Forecast 2024-2032
... set to reach a revenue of $23164.24 million by 2032. MARKET INSIGHTS The Germany RNA interference (RNAi) drug delivery market is experiencing significant growth, driven by the increasing demand for RNAi therapeutics. This surge in ... Read More
-
South Korea Rna Interference (Rnai) Drug Delivery Market Forecast 2024-2032
... It is set to reach a revenue of $6901.97 million by 2032. MARKET INSIGHTS The South Korea RNA interference (RNAi) drug delivery market is witnessing growth and interest due to several key factors. One of ... Read More
-
Global RNAi for Therapeutic Competitive Landscape Professional Research Report 2024
... cells. RNAi is a mechanism where small RNA molecules, such as small interfering RNA (siRNA) or microRNA (miRNA), interfere with the translation or stability of specific messenger RNA (mRNA) molecules, thereby preventing the synthesis of ... Read More
-
RNAi Technology Market Size, Share & Trends Analysis Report By Product & Services (Products, Services), By Application (Drug Discovery & Development, Functional Genomics), By End-use, By Region, And Segment Forecasts, 2024 - 2030
... Technology Market Growth & Trends The global RNAi technology market size is anticipated to reach USD 6.65 billion by 2030 and is growing at a CAGR of 14.6% from 2024 to 2030, according to a ... Read More
-
Biologics Market by Source (Mammalian, Microbial), Product (Antisense & RNAi Therapeutics, Monoclonal Antibodies, Recombinant Hormones or Proteins), Indication, End-user - Global Forecast 2024-2030
... 2023 and expected to reach USD 430.59 billion in 2024, at a CAGR 6.39% to reach USD 626.34 billion by 2030. Biologics are integral to the biomedical sector, focusing on developing, manufacturing, and distributing biological ... Read More
-
RNA Therapeutics Market Assessment, By Type [RNA Interference Therapeutics, mRNA Therapeutics, Antisense Oligonucleotide Therapeutics, Others], By Product [Vaccines, Drugs], By Indication [Rare Genetic Diseases/Hereditary Diseases, Infectious Diseases, Others], By End-user [Hospitals, Academic Research Centers, Contract Research Organizations, Others], By Region, Opportunities and Forecast, 2017-2031F
... Contract Research Organizations, Others], By Region, Opportunities and Forecast, 2017-2031F Global RNA therapeutics market size was valued at USD 23,067.85 million in 2023, expected to reach USD 54,464.95 million in 2031, with a CAGR of ... Read More
-
Antisense and RNAi Therapeutics
... to reach US$3.6 Billion by 2030, growing at a CAGR of 8.1% over the period 2023-2030. Antisense RNA Technology, one of the segments analyzed in the report, is expected to record 7.8% CAGR and reach ... Read More
-
Global RNAi Therapeutics Market (by Molecule Type, Application, End-User & Region): Insights & Forecast with Potential Impact of COVID-19 (2024-2028)
... in 2028, progressing at a CAGR of 10.02%, over the period 2024-2028. Factors such as rising utilization in oncology pharmaceuticals, accelerating growth rates of infectious diseases, enlarging geriatric population, increasing prevalence of neurodegenerative disorders and ... Read More
-
Global Oligonucleotide Therapeutics Market 2024-2028
... therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, ... Read More
-
RNA Therapeutics Market Size, Trends, Analysis, and Outlook By Product (Vaccines, Drugs), By Type (mRNA Therapeutics, RNA Interference (RNAi) Therapeutics, Antisense Oligonucleotide (ASO) Therapeutics, Others), By Indication (Infectious Diseases, Rare Genetic Diseases/Hereditary Diseases, Others), By End-User (Hospitals and Clinics, Research Settings), by Country, Segment, and Companies, 2024-2032
... By End-User (Hospitals and Clinics, Research Settings), by Country, Segment, and Companies, 2024-2032 The global RNA Therapeutics market size is poised to register 8.9% growth from 2024 to 2032, presenting significant growth prospects for companies ... Read More
-
Gene Editing Market Size, Trends, Analysis, and Outlook By Products and Services (Reagents & Consumables, Software & Systems, Services), By Technology (CRISPR, TALEN, ZFN, ANTISENSE, Others), By Application (Cell Line Engineering, Genetic Engineering, Drug Discovery & Development, Others), By End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Others), by Country, Segment, and Companies, 2024-2032
... Discovery & Development, Others), By End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Others), by Country, Segment, and Companies, 2024-2032 The global Gene Editing market size is poised to register 16.5% growth from 2024 ... Read More
-
Biopharmaceutical Contract Manufacturing Market Size, Trends, Analysis, and Outlook By Product (Biologics, Monoclonal Antibodies (MABs), Recombinant Proteins, Vaccines, Antisense, RNAi & Molecular Therapy, Biosimilars), By Source (Mammalian, Non-Mammalian), By Service (Process Development, Fill And Finish Operations, Analytical And QC Studies, Packaging), By Application (Clinical, Commercial), by Country, Segment, and Companies, 2024-2032
... Finish Operations, Analytical And QC Studies, Packaging), By Application (Clinical, Commercial), by Country, Segment, and Companies, 2024-2032 The global Biopharmaceutical Contract Manufacturing market size is poised to register 8.3% growth from 2024 to 2032, presenting ... Read More
-
RNA Interference (RNAi) Drug Delivery Market Report by Application (Infectious Disease, Cardiology, Oncology, Neurology, Ophthalmology, Urology, Metabolic Disorders, and Others), Technology (Nanoparticle Drug Delivery, Pulmonary Drug Delivery, Nucleic Acid Drug Delivery, Aptamer Drug Delivery), and Region 2024-2032
... and Region 2024-2032 The global RNA interference (RNAi) drug delivery market size reached US$ 84.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 410.3 Billion by 2032, exhibiting a growth ... Read More
-
Olpasiran Market Size, Forecast, and Emerging Insight − 2032
... picture of the olpasiran for myocardial infarction in the 7MM, i.e., the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan for the study period 2019 –2032 is provided in ... Read More
Research Assistance
